You have 9 free searches left this month | for more free features.

5-FU

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ive Exposure to 5-FU in Locally Advanced, Resectable Gastric or

Recruiting
  • TDM of 5-FU
  • Pharmacokinetic Observational Study
  • Extra blood samples for determining exposure to 5-FU
  • Eindhoven, Noord-Brabant, Netherlands
    Catharina hospital
Dec 28, 2022

Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Shreveport, Louisiana
  • +3 more
Oct 3, 2023

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Nanoliposomal irinotecan
  • +3 more
  • Brugge, West-Vlaanderen, Belgium
  • +11 more
Jul 25, 2022

Basal Cell Carcinoma, BCC Trial in Aleppo (5-Fluorouracil, SURGERY)

Recruiting
  • Basal Cell Carcinoma
  • BCC
  • Aleppo, Syrian Arab Republic
    Ibrahim Arnaout
Nov 28, 2023

Carcinoma, Squamous Cell Trial in Pittsburgh (5-fluorouracil, Imiquimod 5% cream)

Recruiting
  • Carcinoma, Squamous Cell
  • Pittsburgh, Pennsylvania
    St. Margaret Hospital Dermatology
Oct 6, 2022

Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Completed
  • Colorectal Cancer
  • Frankfurt, Germany
  • +1 more
Oct 3, 2022

Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)

Not yet recruiting
  • Actinic Keratosis
  • Biopsy
  • +2 more
  • Tucson, Arizona
  • +3 more
Jan 25, 2023

Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))

Recruiting
  • Rectal Cancer
  • mFOLFOX (neoadjuvant)
  • +6 more
  • Mannheim, Germany
    Unversity Hospital Mannheim
Aug 12, 2022

Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • nanoliposomal irinotecan
  • spleen irradiation
  • (no location specified)
May 8, 2022

CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))

Not yet recruiting
  • CIN 2/3
  • HIV Infections
  • Intravaginal 5-Fluorouracil (5-FU)
  • Lilongwe, Malawi
    UNC Project, Kamuzu Central Hospital
Jan 17, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

Recruiting
  • Colorectal Cancer
  • +4 more
  • Fosifloxuridine Nafalbenamide
  • +4 more
  • Wichita, Kansas
  • +5 more
Jan 9, 2023

Actinic Keratoses Trial in Worldwide (5-fluorouracil 4% (Tolak), Dexeryl)

Completed
  • Actinic Keratoses
  • 5-fluorouracil 4% (Tolak)
  • Dexeryl
  • Arras, France
  • +26 more
Sep 15, 2022

Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • FOX dose-escalation algorithm
  • (no location specified)
Mar 24, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Temporal Bone Squamous Cell Carcinoma Trial in Guangzhou (Paprizumab combined with cisplatin and 5-FU)

Recruiting
  • Temporal Bone Squamous Cell Carcinoma
  • Paprizumab combined with cisplatin and 5-FU
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 5, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus

Not yet recruiting
  • Stage II Colon Cancer
  • Stage III Colon Cancer
  • 5-Fluorouracil continuous infusion FOLFOXIRI schedule
  • +8 more
  • (no location specified)
Aug 3, 2022

5-FU Exposure Optimization in CRC Patients

Completed
  • Metastatic Colorectal Cancer
  • +2 more
    • La Jolla, California
    • +4 more
    Feb 15, 2022

    Oral Leukoplakia Trial in San Francisco (5-fluorouracil)

    Not yet recruiting
    • Oral Leukoplakia
    • San Francisco, California
      University of California, San Francisco
    Aug 15, 2022

    Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

    Terminated
    • Colorectal Cancer
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jan 10, 2022

    Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Madrid, Spain
      Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
    Oct 10, 2022